Latest News

23/03/2020

Emergence Therapeutics to Attend Upcoming Conferences

Emergence Therapeutics, a new European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers, announces that Dr. Jack Elands, Chief Executive Officer of Emergence Therapeutics, will be attending the following upcoming conferences in 2020: Bio Europe Spring Date: March 23 – 25 Location: Virtual ASCO Date: May 29 – June...

View Article >
23/03/2020

Emergence Tx New Website Launch

Dr. Jack Elands, Chief Executive Officer of Emergence Therapeutics, to participate in Bio-Europe Spring digital event on 23-27 March Emergence Therapeutics, a new European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers, has launched its new company website. Emergence Therapeutics’ science is being harnessed to develop best- or first-in-class...

View Article >

Latest Events

When:

March 23,24 & 25

Where:

Bio Europe Spring (virtual)

Location:

Paris

Website:

View Event >

When:

29 May–2 June

Where:

ASCO

Location:

Chicago

Website:

View Event >

When:

June 8-11

Where:

Bio International

Location:

San Diego

Website:

View Event >

When:

June 22 & 23

Where:

Health Tech Investor Forum

Location:

Paris

Website:

View Event >

When:

September 15-18

Where:

World ADC

Location:

San Diego

Website:

View Event >

When:

October 26-28

Where:

Bio Europe

Location:

Munich

Website:

View Event >